Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Magenta Therapeutics Inc.

    NASDAQ: MGTA · Real-Time Price · USD
    0.70
    -0.06 (-7.69%)
    At close: Sep 11, 2023, 8:00 PM

    Magenta Therapeutics Statistics

    Share Statistics

    Magenta Therapeutics has 60.66M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 60.66M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 2,075

    FTD / Avg. Volume

    n/a
    		 0.84%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -0.02 and the forward PE ratio is null. Magenta Therapeutics's PEG ratio is -0.01.

    PE Ratio

    n/a
    		 -0.02

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.01

    P/FCF Ratio

    n/a
    		 -0.02

    PEG Ratio

    n/a
    		 -0.01
    Financial Ratio History

    Enterprise Valuation

    Magenta Therapeutics has an Enterprise Value (EV) of -26.43M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 0.33

    EV / EBIT

    n/a
    		 0.39

    EV / FCF

    n/a
    		 0.39

    Financial Position

    The company has a current ratio of 7.95, with a Debt / Equity ratio of 0.28.

    Current Ratio

    n/a
    		 7.95

    Quick Ratio

    n/a
    		 7.95

    Debt / Equity

    n/a
    		 0.28

    Debt / EBITDA

    n/a
    		 -0.38

    Debt / FCF

    n/a
    		 -0.44

    Interest Coverage

    n/a
    		 18.22

    Financial Efficiency

    Return on Equity is -67.97% and Return on Invested Capital is -56.07%.

    Return on Equity

    n/a
    		 -67.97%

    Return on Assets

    n/a
    		 -49.11%

    Return on Invested Capital

    n/a
    		 -56.07%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,074,955.22

    Employee Count

    n/a
    		 67

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -4.44M

    Effective Tax Rate

    n/a
    		 5.81%

    Stock Price Statistics

    The stock price has increased by 0.06% in the last 52 weeks. The beta is 2.11, so Magenta Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.11

    52-Week Price Change

    n/a
    		 0.06%

    50-Day Moving Average

    n/a
    		 0.78

    200-Day Moving Average

    n/a
    		 0.75

    Relative Strength Index (RSI)

    n/a
    		 36.83

    Average Volume (20 Days)

    n/a
    		 247,981

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -80.9M

    Net Income

    n/a
    		 -72.02M

    EBITDA

    n/a
    		 -78.98M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -23.05
    Full Income Statement

    Balance Sheet

    The company has 57.63M in cash and 29.96M in debt, giving a net cash position of 27.66M.

    Cash & Cash Equivalents

    n/a
    		 57.63M

    Total Debt

    n/a
    		 29.96M

    Net Cash

    n/a
    		 27.66M

    Retained Earnings

    n/a
    		 -402.03M

    Total Assets

    n/a
    		 192.46M

    Working Capital

    n/a
    		 178.37M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -67.09M and capital expenditures -314K, giving a free cash flow of -67.4M.

    Operating Cash Flow

    n/a
    		 -67.09M

    Capital Expenditures

    n/a
    		 -314K

    Free Cash Flow

    n/a
    		 -67.4M

    FCF Per Share

    n/a
    		 -21.57
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    MGTA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -5834.95%

    FCF Yield

    n/a
    		 -5460.82%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for MGTA.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 1.64

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist